169 related articles for article (PubMed ID: 30385066)
1. Environmental risk assessment of metformin and its transformation product guanylurea: II. Occurrence in surface waters of Europe and the United States and derivation of predicted no-effect concentrations.
Caldwell DJ; D'Aco V; Davidson T; Kappler K; Murray-Smith RJ; Owen SF; Robinson PF; Simon-Hettich B; Straub JO; Tell J
Chemosphere; 2019 Feb; 216():855-865. PubMed ID: 30385066
[TBL] [Abstract][Full Text] [Related]
2. Environmental risk assessment of metformin and its transformation product guanylurea. I. Environmental fate.
Straub JO; Caldwell DJ; Davidson T; D'Aco V; Kappler K; Robinson PF; Simon-Hettich B; Tell J
Chemosphere; 2019 Feb; 216():844-854. PubMed ID: 30449313
[TBL] [Abstract][Full Text] [Related]
3. Consideration of exposure and species sensitivity of triclosan in the freshwater environment.
Capdevielle M; Van Egmond R; Whelan M; Versteeg D; Hofmann-Kamensky M; Inauen J; Cunningham V; Woltering D
Integr Environ Assess Manag; 2008 Jan; 4(1):15-23. PubMed ID: 18260205
[TBL] [Abstract][Full Text] [Related]
4. Environmental Risk Assessment for the Active Pharmaceutical Ingredient Mycophenolic Acid in European Surface Waters.
Straub JO; Oldenkamp R; Pfister T; Häner A
Environ Toxicol Chem; 2019 Oct; 38(10):2259-2278. PubMed ID: 31225916
[TBL] [Abstract][Full Text] [Related]
5. Human health risk assessment of carbamazepine in surface waters of North America and Europe.
Cunningham VL; Perino C; D'Aco VJ; Hartmann A; Bechter R
Regul Toxicol Pharmacol; 2010 Apr; 56(3):343-51. PubMed ID: 19883710
[TBL] [Abstract][Full Text] [Related]
6. Incomplete aerobic degradation of the antidiabetic drug Metformin and identification of the bacterial dead-end transformation product Guanylurea.
Trautwein C; Kümmerer K
Chemosphere; 2011 Oct; 85(5):765-73. PubMed ID: 21752423
[TBL] [Abstract][Full Text] [Related]
7. Aquatic environmental risk assessment for human use of the old antibiotic sulfamethoxazole in Europe.
Straub JO
Environ Toxicol Chem; 2016 Apr; 35(4):767-79. PubMed ID: 25693841
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive study of the antidiabetic drug metformin and its transformation product guanylurea in Greek wastewaters.
Kosma CI; Lambropoulou DA; Albanis TA
Water Res; 2015 Mar; 70():436-48. PubMed ID: 25562582
[TBL] [Abstract][Full Text] [Related]
9. Environmental risk assessment of hydrotropes in the United States, Europe, and Australia.
Stanton K; Tibazarwa C; Certa H; Greggs W; Hillebold D; Jovanovich L; Woltering D; Sedlak R
Integr Environ Assess Manag; 2010 Jan; 6(1):155-63. PubMed ID: 19558203
[TBL] [Abstract][Full Text] [Related]
10. An Environmental Risk Assessment for Human-Use Trimethoprim in European Surface Waters.
Straub JO
Antibiotics (Basel); 2013 Mar; 2(1):115-62. PubMed ID: 27029296
[TBL] [Abstract][Full Text] [Related]
11. An environmental risk assessment for oseltamivir (Tamiflu) for sewage works and surface waters under seasonal-influenza- and pandemic-use conditions.
Straub JO
Ecotoxicol Environ Saf; 2009 Sep; 72(6):1625-34. PubMed ID: 19560203
[TBL] [Abstract][Full Text] [Related]
12. Exposure assessment of 17alpha-ethinylestradiol in surface waters of the United States and Europe.
Hannah R; D'Aco VJ; Anderson PD; Buzby ME; Caldwell DJ; Cunningham VL; Ericson JF; Johnson AC; Parke NJ; Samuelian JH; Sumpter JP
Environ Toxicol Chem; 2009 Dec; 28(12):2725-32. PubMed ID: 19645524
[TBL] [Abstract][Full Text] [Related]
13. Occurrence of the antidiabetic drug Metformin and its ultimate transformation product Guanylurea in several compartments of the aquatic cycle.
Trautwein C; Berset JD; Wolschke H; Kümmerer K
Environ Int; 2014 Sep; 70():203-12. PubMed ID: 24954924
[TBL] [Abstract][Full Text] [Related]
14. Occurrence, Impact, Analysis and Treatment of Metformin and Guanylurea in Coastal Aquatic Environments of Canada, USA and Europe.
Tao Y; Chen B; Zhang BH; Zhu ZJ; Cai Q
Adv Mar Biol; 2018; 81():23-58. PubMed ID: 30471658
[TBL] [Abstract][Full Text] [Related]
15. Occurrence and fate of the antidiabetic drug metformin and its metabolite guanylurea in the environment and during drinking water treatment.
Scheurer M; Michel A; Brauch HJ; Ruck W; Sacher F
Water Res; 2012 Oct; 46(15):4790-802. PubMed ID: 22770965
[TBL] [Abstract][Full Text] [Related]
16. Environmental risk assessment of musk ketone and musk xylene in The Netherlands in accordance with the EU-TGD.
Tas JW; Balk F; Ford RA; van de Plassche EJ
Chemosphere; 1997 Dec; 35(12):2973-3002. PubMed ID: 9415982
[TBL] [Abstract][Full Text] [Related]
17. Combined environmental risk assessment for 5-fluorouracil and capecitabine in Europe.
Straub JO
Integr Environ Assess Manag; 2010 Jul; 6 Suppl():540-66. PubMed ID: 19958049
[TBL] [Abstract][Full Text] [Related]
18. Presence, fate and effects of the intense sweetener sucralose in the aquatic environment.
Tollefsen KE; Nizzetto L; Huggett DB
Sci Total Environ; 2012 Nov; 438():510-6. PubMed ID: 23032567
[TBL] [Abstract][Full Text] [Related]
19. Aquatic risk assessment of alcohol ethoxylates in North America and Europe.
Belanger SE; Dorn PB; Toy R; Boeije G; Marshall SJ; Wind T; Van Compernolle R; Zeller D
Ecotoxicol Environ Saf; 2006 May; 64(1):85-99. PubMed ID: 16439022
[TBL] [Abstract][Full Text] [Related]
20. Dichloromethane marine risk assessment with special reference to the OSPARCOM region: North Sea.
De Rooij C; Thompson RS; Garny V; Lecloux A; van Wijk D
Environ Monit Assess; 2004 Oct; 97(1-3):3-22. PubMed ID: 15376376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
